Rubella Immunity in Pregnant Iranian Women: A Systematic Review and Meta-Analysis.
Immunity
Iran
Meta-Analysis
Pregnant Women
Rubella
Journal
International journal of fertility & sterility
ISSN: 2008-076X
Titre abrégé: Int J Fertil Steril
Pays: Iran
ID NLM: 101487941
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
05
05
2018
accepted:
15
01
2019
entrez:
17
7
2019
pubmed:
17
7
2019
medline:
17
7
2019
Statut:
ppublish
Résumé
Rubella infection within the first trimester of pregnancy may lead to adverse pregnancy outcomes. The present study was conducted to evaluate the immunity against rubella among the pregnant Iranian women. The steps of meta-analyses were conducted based on the MOOSE protocol and results were reported according to the PRISMA guideline. To review the associated English and Persian literature, a comprehensive search was conducted among the international databases such as Scopus, PubMed/Medline, Science Direct, Embase, Cochrane library, Web of Science and Google Scholar search engine as well as Iranian databases, until April 1, 2018 using the following medical subject headings (MeSH) keywords: 'Pregnant', 'Gestational', 'Prenatal care', 'Complications of pregnancy', 'Pregnancy', 'Rubella infection', 'Prevalence, 'Epidemiology', 'Immunity', 'Immunization', 'Antibody', 'Immunogenicity' and 'Iran'. Cochran's Q test and I2 index were used to investigate heterogeneity in the studies. Random effects model was used to estimate the rate of rubella immunity. The obtained data were analyzed using Comprehensive Meta-Analysis Ver.2. Fifteen studies constituting 7,601 pregnant Iranian women met the inclusion criteria. The overall pooled rubella immunity rate was 90.1% [95% confidence interval (CI): 86.1-93.1]. Rubella immunity rates were respectively 88.6% (95% CI: 80.6-93.6) and 91.5% (95% CI: 88.1-93.9) before and after national vaccine program. Rubella immunity rates were 91.4% (95% CI: 87.8-94.0) and 87.2% (95% CI: 74.3-94.1) based on the enzyme-linked immunosorbent assay (ELISA) and haemagglutination-inhibition (HAI) methods, respectively. There was no significant association between rubella immunity and vaccination program (P=0.398), diagnostic methods (P=0.355), geographic regions (P=0.286), quality of the studies (P=0.751), occupation (P=0.639), residence (P=0.801), and year of the studies (P=0.164), but it was significantly associated with age (P<0.001). Despite high rubella immunity among the pregnant Iranian women, anti-rubella antibody screening is recommended for all women of childbearing age.
Identifiants
pubmed: 31310069
doi: 10.22074/ijfs.2019.5562
pmc: PMC6642423
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
169-177Informations de copyright
Copyright© by Royan Institute. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Southeast Asian J Trop Med Public Health. 2013 May;44(3):429-35
pubmed: 24050074
MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):457-62
pubmed: 23760185
Gac Med Mex. 2001 Mar-Apr;137(2):105-9
pubmed: 11381796
Int J Gynaecol Obstet. 2012 Mar;116(3):211-3
pubmed: 22233835
Virol J. 2011 May 11;8:217
pubmed: 21569321
J Clin Microbiol. 1981 May;13(5):850-4
pubmed: 7016910
Lancet. 2015 Jun 6;385(9984):2297-307
pubmed: 25576992
Salud Publica Mex. 1993 Jul-Aug;35(4):339-44
pubmed: 8342079
Med Decis Making. 2005 Nov-Dec;25(6):646-54
pubmed: 16282215
J Clin Med Res. 2016 Sep;8(9):656-61
pubmed: 27540439
Am J Trop Med Hyg. 2017 Feb 8;96(2):411-414
pubmed: 27895276
Epidemiol Infect. 2012 Dec;140(12):2290-301
pubmed: 22335852
East Mediterr Health J. 2008 May-Jun;14(3):590-4
pubmed: 18720623
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
PLoS One. 2013;8(1):e55043
pubmed: 23383049
Pediatr Infect Dis J. 2007 Dec;26(12):1137-41
pubmed: 18043452
New Microbiol. 2008 Oct;31(4):451-5
pubmed: 19123299
Am J Trop Med Hyg. 2010 Jan;82(1):40-4
pubmed: 20064993
J Infect Dis. 2011 Jul;204 Suppl 1:S215-25
pubmed: 21666164
Salud Publica Mex. 1999 Jul-Aug;41(4):271-7
pubmed: 10624138
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34
pubmed: 23760231
BMC Infect Dis. 2013 Apr 04;13:164
pubmed: 23556510
Wkly Epidemiol Rec. 2011 Jul 15;86(29):301-16
pubmed: 21766537
J Clin Microbiol. 1985 Feb;21(2):161-3
pubmed: 3972983
Indian Pediatr. 2012 May;49(5):377-99
pubmed: 22700664
J Res Med Sci. 2018 Jan 29;23:8
pubmed: 29456565
Niger J Clin Pract. 2011 Apr-Jun;14(2):140-5
pubmed: 21860127
ACP J Club. 1995 Nov-Dec;123(3):A12-3
pubmed: 7582737
Med Monatsschr Pharm. 2012 Jan;35(1):14-22; quiz 23-4
pubmed: 22332308
J Infect Dev Ctries. 2014 Mar 13;8(3):389-90
pubmed: 24619273
Int J Infect Dis. 2016 Aug;49:196-201
pubmed: 27196370